The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer

CONCLUSIONS: Our findings describe a novel genomic feature in metastatic prostate cancer and suggest that PIK3R1 alteration may be a key event for insulin-PI3K-glycolytic pathway regulation in prostate cancer.PMID:35670774 | DOI:10.1158/1078-0432.CCR-21-4272
Source: Clinical Cancer Research - Category: Cancer & Oncology Authors: Source Type: research